Prior maze experience required to alter midazolam effects in rats submitted to the elevated plus-maze

Pharmacology Biochemistry and Behavior

Volumn 72, Issue 1-2, 2002, Pages 449-455

  Bertoglio, L J ^a   Carobrez, A P ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Anxiety; Elevated plus maze; Midazolam; One trial tolerance; Open arm avoidance; Rat

Indexed keywords

MIDAZOLAM; ANXIOLYTIC AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; DRUG EFFICACY; EXPLORATORY BEHAVIOR; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; TASK PERFORMANCE; TRANQUILIZING ACTIVITY; ANIMAL; ANXIETY; COMPARATIVE STUDY; DOSE RESPONSE; PHYSIOLOGY; WISTAR RAT;

RODENTIA;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; MALE; MAZE LEARNING; MIDAZOLAM; RATS; RATS, WISTAR;

EID: 0036204816     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(02)00710-4     Document Type: Article

References (37)

1. Previous maze experience required to increase open arms avoidance in rats submitted to the elevated plus-maze model of anxiety
2. Behavioral profile of rats submitted to session 1-session 2 in the elevated plus-maze during diurnal/nocturnal phases and under different illumination conditions
3. Use of elevated plus-maze in the search for novel anxiolytic agents
4. One-trial tolerance to the effects of chlordiazepoxide on the elevated plus-maze may be due to locomotor habituation, not repeated drug exposure
5. NMDA-coupled periaqueductal gray glycine receptors modulate anxioselective drug effects on plus-maze performance
6. The influence of open arm ledges and maze experience in the elevated plus-maze
7. Behavioral detection of anxiolytic action
8. The interplay of learning and anxiety in the elevated plus-maze
9. One-trial tolerance to the anxiolytic actions of the benzodiazepines in the elevated plus-maze, or the development of a phobic state?
10. Characterization of phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze
11. Trial 2 in the elevated plus-maze: A different form of fear?
12. Role of the basolateral nucleus of the amygdala in the formation of a phobia
13. Role of the dorsomedial hypothalamus in mediating the response to benzodiazepines on trial 2 in the elevated plus-maze test of anxiety
14. A five-minute experience in the elevated plus-maze alters the state of the benzodiazepine receptor in the dorsal raphe nucleus
15. Some critical determinants of the behavior of rats in the elevated plus-maze
16. 1A receptor antagonists in three rat models of anxiety
17. 5-HT drugs in animal models of anxiety
18. Influence of prior experience on mice behavior using the four-plate test
19. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety
20. Responses of Swiss-Webster mice to repeated plus-maze experience: Further evidence for qualitative shift in emotional state?
21. Influence of spatial and temporal manipulations on the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus-maze
22. Prior test experience compromises the anxiolytic efficacy of chlordiazepoxide in the mouse light/dark exploration test
23. Effects of drugs on punished behavior: Preclinical test for anxiolytics
24. The use of a plus-maze to measure anxiety in the mouse
25. Ethologically based animal models of anxiety disorders
26. Differential anxiolytic efficacy of a benzodiazepine on first versus second exposure to a predatory odor in rats
27. Effects of centrally administered anxiolytic compounds in animal models of anxiety
28. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
29. The phenomenon of "one trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze is abolished by the introduction of a motivational conflict situation
30. Animal models of anxiety: Where next?
31. The elevated plus-maze: Pharmacology, methodology and ethology
32. Influence of prior maze experience on behavior and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice
33. Plus-maze retest profile: Importance of initial stages of trial 1 and response to post-trial cholinergic receptor blockade in mice
34. Resistance of experientially induced changes in murine plus-maze behavior to altered retest conditions
35. Temporal analysis of the rat's behavior in the plus-maze: Effect of midazolam
36. Effects of glycine or (±)-3-amino-1-hydroxy-2-pyrrolidone microinjections along the rostrocaudal axis of the dorsal periaqueductal gray matter on rats' performance in the elevated plus-maze task
37. Anxiogenic stimuli in the elevated plus-maze